​

Funding Round

Series B - RVAC Medicines

Series B - RVAC Medicines

Investment Firm

Overview

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.

Announced Date

Apr 26, 2022

Funding Type

Series B

Highlights

Location

Asia

Social

Investor Lead

C-Bridge Capital

C-Bridge Capital

C-Bridge Capital is a debt and early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

4

Investor Name
Participant InvestorGS Holdings
Participant InvestorPavilion Capital
Participant InvestorC-Bridge Capital
Participant InvestorEDBI

Round Details and Background

RVAC Medicines raised $140000000 on 2022-04-26 in Series B

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 26, 2022
Series B - RVAC Medicines
4-140.0M

Recent Activity

There is no recent news or activity for this profile.